Integrating Process and Structure in Borderline Personality Disorder
边缘性人格障碍的整合过程和结构
基本信息
- 批准号:8033821
- 负责人:
- 金额:$ 31.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressBehaviorBenchmarkingBorderline Personality DisorderBoredomCategoriesChronicClinicalCognitiveDataDependencyDevelopmentDiagnosisDiseaseDisease remissionDistressEnvironmentEtiologyFrequenciesGoalsHealth Care CostsIndividualJudgmentKnowledgeLeadMeasurementMeasuresMethodologyParticipantPathway interactionsPatient Self-ReportPatternPerceptionPersonalityPersonality DisordersPersonsPopulationProblem SolvingProcessPsychosocial FactorQualifyingQuestionnairesReport (account)ReportingResearchResearch ProposalsRiskRoleSamplingSeveritiesSocial PerceptionSocietiesStagingStructureSuicideSymptomsTechniquesTestingTimeTreatment Efficacybasebehavioral/social scienceclinical Diagnosiscostdesigneffective therapyexperiencefunctional disabilityimprovedinformantinnovationinsightlongitudinal designpublic health relevanceresearch clinical testingsevere mental illnesssocialstressortooltrait
项目摘要
DESCRIPTION (provided by applicant): Borderline Personality Disorder (BPD) is a serious mental illness, associated with severe functional impairment and significant costs to society. Two significant problems impede successful diagnosis and treatment of these debilitating disorders. First is an almost complete lack of direct, empirical knowledge about actual symptom expression, frequency, or severity. Clinical diagnosis relies on comparisons of individual's symptom levels to normal frequencies and severities, but there is no direct, empirical knowledge about actual levels of symptom expression in either a normal or abnormal population. This limitation in data availability to the clinician makes it difficult to determine whether a given individual's symptoms qualify for diagnosis, are being effectively treated, or are reduced to healthy levels. A second significant problem is that there is little information about the processes underlying BPD and associated problems. Without knowledge of the underlying causal mechanisms, it is difficult to optimize effective treatment of BPD. The following research proposal is tailored to simultaneously address both of these significant problems. In R01 MH70571, Stage 1, an innovative approach that is particularly suited to solving these problems was developed and successfully applied to the study of normal personality. This approach is characterized by two hallmarks: (1) measuring actual behavior to describe and explain personality, rather than relying on retrospective questionnaires; and (2) leveraging variability in behavior to identify the mechanisms underlying personality. Stage 1 verified the usefulness of this approach for arriving at new insights about personality and for explaining the mechanisms underlying personality. Stage 2 will use this approach to accomplish the same goals for BPD. Stage 2 will measure actual symptoms rather than rely on retrospective reports, and will leverage variability in those symptoms to test the mechanisms underlying BPD. Aim 1 is to obtain direct, empirical accounts of symptom frequencies, severities, and co-occurrences, to aid diagnosis, treatment, and termination decisions. Aim 2 is to propose and test several theoretical mechanisms for BPD. Aim 3 is to investigate the role of interpersonal perception processes in stressors and symptoms. Aim 4 is to chart trajectories and transactions of symptom frequencies, severities, and contingencies. Borderline Personality Disorder, like normal personality, is often considered chronic and untreatable. However, this is a serious mental illness, associated with severe functional impairment, high health-care costs, and significant suffering. The key to finding treatments and reducing these costs is to find an approach that unlocks the mechanism underlying the disorder. Stage 1 demonstrated such an approach for normal personality; Stage 2 will do the same for borderline personality disorder.
PUBLIC HEALTH RELEVANCE: Borderline Personality Disorder is a serious mental illness, associated with severe personal distress, suicidality, interpersonal instability, and significant costs to society. The proposed research is tailored to address several significant problems in the understanding of this destructive disorder. By advancing understanding of the psychosocial factors that trigger its symptoms, we hope to improve diagnosis and treatment in a way that helps alleviate the personal and societal costs associated with borderline personality disorder.
描述(由申请人提供):边缘型人格障碍(BPD)是一种严重的精神疾病,与严重的功能障碍和重大的社会成本相关。有两个重大问题阻碍了这些使人衰弱的疾病的成功诊断和治疗。首先是几乎完全缺乏关于实际症状表现、频率或严重程度的直接经验知识。临床诊断依赖于个体症状水平与正常频率和严重程度的比较,但对于正常或异常人群中症状表达的实际水平没有直接的经验知识。临床医生可获得数据的这种限制使得难以确定特定个体的症状是否符合诊断条件,是否正在得到有效治疗,或是否已降至健康水平。第二个重要的问题是,关于BPD背后的流程和相关问题的信息很少。如果不了解潜在的因果机制,就很难优化有效的BPD治疗。下面的研究计划是量身定制的,以同时解决这两个重大问题。在R01 MH70571,阶段1中,一种特别适合解决这些问题的创新方法被开发出来,并成功地应用于正常人格的研究。该方法有两个特点:(1)通过测量实际行为来描述和解释人格,而不是依靠回顾性问卷;(2)利用行为的可变性来识别人格的潜在机制。第一阶段验证了这一方法在获得关于人格的新见解和解释人格背后的机制方面的有效性。阶段2将使用这种方法来完成BPD的相同目标。第2阶段将测量实际症状,而不是依赖于回顾性报告,并利用这些症状的可变性来测试BPD的潜在机制。目的1是获得症状频率、严重程度和共现症的直接、经验性描述,以帮助诊断、治疗和终止决定。目的2是提出和测试BPD的几个理论机制。目的3是探讨人际知觉过程在应激源和症状中的作用。目标4是图表的轨迹和交易的症状频率,严重程度,和突发事件。与正常人格一样,边缘型人格障碍通常被认为是慢性的,无法治愈的。然而,这是一种严重的精神疾病,与严重的功能障碍、高昂的医疗费用和巨大的痛苦有关。找到治疗方法和降低这些费用的关键是找到一种方法来解开这种疾病的潜在机制。第一阶段展示了正常人格的这种方法;第二阶段将对边缘型人格障碍进行同样的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM W FLEESON其他文献
WILLIAM W FLEESON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM W FLEESON', 18)}}的其他基金
Integrating Process and Structure in Borderline Personality Disorder
边缘性人格障碍的整合过程和结构
- 批准号:
8585880 - 财政年份:2005
- 资助金额:
$ 31.18万 - 项目类别:
Integrating Process and Structure in Borderline Personality Disorder
边缘性人格障碍的整合过程和结构
- 批准号:
8197142 - 财政年份:2005
- 资助金额:
$ 31.18万 - 项目类别:
Integrating Process and Structure in Borderline Personality Disorder
边缘性人格障碍的整合过程和结构
- 批准号:
7788276 - 财政年份:2005
- 资助金额:
$ 31.18万 - 项目类别:
Integrating Process and Structure in Borderline Personality Disorder
边缘性人格障碍的整合过程和结构
- 批准号:
8372300 - 财政年份:2005
- 资助金额:
$ 31.18万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.18万 - 项目类别:
Research Grant